Ocular Therapeutix, Inc. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-22.4% -$4M
$13M
Cost of Revenue↑+29.6% +$364K
$2M
R&D↑+23.9% +$10M
$51M
D&A↑+31.1% +$296K
$1M
Operating Income↓-49.3% -$23M
$-69M
EBITDA↑+31.1% +$296K
$1M
Interest Expense↓-8.8% -$274K
$3M
Net Income↓-90.2% -$33M
$-69M
Operating Margin↓-174.1pts
-472.3%
Net Margin↓-240.7pts
-477.3%
ETR (Continuing Operations)
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)
1.8%
Operating Lease Cost↑+26.0% +$365K
$2M
Revenue YoY Variation↓-37.8pts
-22.4%
Income YoY Variation↑+90.0pts
-49.3%
Revenue QoQ Variation↓-19.6pts
-8.9%
Income QoQ Variation↑+4.0pts
-1.6%